TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance

U.S. Markets close in 4 hrs 49 mins

Teva Pharmaceutical Industries Limited (TEVA)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
33.97+0.03 (+0.09%)
At close: 4:00PM EST
People also watch
MYLNVSGILDAMGNABT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close33.94
Open34.25
Bid0.00 x
Ask0.00 x
Day's Range33.86 - 34.47
52 Week Range33.56 - 64.31
Volume12,592,066
Avg. Volume10,386,579
Market Cap34.48B
Beta0.47
PE Ratio (TTM)22.69
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.36 (4.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Forbes3 hours ago

    5 Trump-Proof Pharma Dividends Up To 5.3%

    Donald Trump needed just 20 minutes to knock $24.6 billion in value from the nine biggest Big Pharma companies. That was the statistic bandied about recently when the president-elect, at a much-anticipated press conference, declared that pharmaceuticals are “getting away with murder.” That’s ironic, because investors targeting the sure-fire dividends of

  • Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended
    Zacks4 hours ago

    Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended

    Eli Lilly and Company (LLY) and Incyte Corporation (INCY) announced that the FDA has extended the time to review the company's NDA for baricitinib for the treatment of rheumatoid arthritis (RA).

  • Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
    Zacks3 days ago

    Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit

    Eli Lilly and Company (LLY) announced that it has received a favorable ruling in a lawsuit against generic drugmaker Teva Pharmaceutical Industries Limited (TEVA) related to the infringement of a vitamin regimen patent for its cancer drug Alimta.